STOCK TITAN

Routine 562-Share Grant Disclosed by MetLife Director in Form 4 Filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Form 4 overview – MetLife, Inc. (MET)

Director Mark A. Weinberger reported a routine equity award on 17 Jun 2025. He received 562 shares of MetLife common stock at a stated price of $0, reflecting the company’s practice of paying a portion of non-management director retainers in shares. Following the transaction, Weinberger’s direct ownership increased to 16,907 shares.

No derivative securities were involved and the filing contains no additional purchases, sales or option exercises. The award appears to be automatic, formula-based compensation and does not signal discretionary buying or selling by the director.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine 562-share director grant; negligible market impact.

This Form 4 simply records a scheduled stock retainer paid to a non-management director. The small size (<1% of daily MET volume) and zero cash outlay indicate no change in sentiment or insider conviction. As such, it should not move valuation models or trading outlooks.

TL;DR: Standard board compensation disclosure; governance practices unchanged.

The transaction aligns with MetLife’s disclosed non-management director pay program, reinforcing transparency. There are no red flags regarding timing, pricing, or insider intent. Governance risk profile remains stable.

Insider WEINBERGER MARK A
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 562 $0.00 --
Holdings After Transaction: Common Stock — 16,907 shares (Direct)
Footnotes (1)
  1. [object Object]
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEINBERGER MARK A

(Last) (First) (Middle)
METLIFE, INC.
200 PARK AVENUE

(Street)
NEW YORK NY 10166

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A(1) 562 A $0 16,907 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
Remarks:
/s/ Morgan Mayes, Authorized Signer 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MetLife (MET) shares did Director Mark A. Weinberger acquire?

He received 562 shares of common stock.

What was the transaction price listed on the Form 4?

The shares were reported at a price of $0, reflecting a board retainer stock grant.

What is Weinberger’s total beneficial ownership after the grant?

His direct ownership increased to 16,907 MET shares.

Was this Form 4 filed under a Rule 10b5-1 trading plan?

The filing does not indicate use of a Rule 10b5-1 plan; it reflects automatic director compensation.

Does the filing involve any derivative securities or options?

No derivative securities were reported in Table II.